Syngene International Limited Share Price & Analysis
₹413.25▼ -1.04%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹413.25
-1.04%
Open
₹—
High
₹417.8
Low
₹412.05
Close
₹413.25
52W High
₹729
52W Low
₹380
Volume
1634K
Lot Size
1
Sector
Healthcare
Market Cap
₹17K Cr
Face Value
₹10
Mid CapNIFTY 500SMALLCAP 100
Price Chart
Fundamentals
P/E
45.3
Sector P/E
54.4
P/B
3.66
EPS
₹7.88
ROE
7.78%
ROCE
9.99%
D/E Ratio
0.09
Div Yield
0.3%
Book Value
₹120
+
Strengths
- ✓Virtually debt-free
- ✓Near 52-week low — potential value zone (₹380)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SYNGENE · as of Mar 2026
Promoters52.74%
FII19.47%▼1.18
DII21.50%▲1.98
Public5.99%▼0.80
Others0.29%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.79% | 54.79% | 54.72% | 54.72% | 52.74% | 52.74% |
| FII | 21.20% | 20.92% | 20.64% | 20.72% | 20.65% | 19.47% |
| DII | 14.63% | 15.80% | 16.78% | 17.49% | 19.52% | 21.50% |
| Public | 9.07% | 8.18% | 7.44% | 6.74% | 6.79% | 5.99% |
| Others | 0.32% | 0.31% | 0.43% | 0.34% | 0.29% | 0.29% |
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Results28 Jul 2026
Dividend - Rs 1.25 Per Share
Record: 25 Jun 2026
Dividend24 Jun 2026
Dividend - Rs 1.25 Per Share
Dividend26 Jun 2025
Dividend - Rs 1.25 Per Share
Dividend27 Jun 2024
Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
Dividend29 Jun 2023
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.0K Cr ▲13.0% | ₹917 Cr ▲0.7% | ₹911 Cr ▲4.2% | ₹874 Cr ▼14.1% | ₹1.0K Cr ▲7.8% | ₹944 Cr ▲5.9% | ₹891 Cr ▲12.8% | ₹790 Cr |
| Op. Profit | ₹303 Cr ▲45.0% | ₹209 Cr ▲4.5% | ₹200 Cr ▼2.9% | ₹206 Cr ▼40.1% | ₹344 Cr ▲21.1% | ₹284 Cr ▲15.9% | ₹245 Cr ▲44.1% | ₹170 Cr |
| OPM | 29.0% ▲26.1% | 23.0% ▲4.5% | 22.0% ▼8.3% | 24.0% ▼29.4% | 34.0% ▲13.3% | 30.0% ▲11.1% | 27.0% ▲22.7% | 22.0% |
| Net Profit | ₹148 Cr ▲886.7% | ₹15 Cr ▼77.6% | ₹67 Cr ▼23.0% | ₹87 Cr ▼52.5% | ₹183 Cr ▲39.7% | ₹131 Cr ▲23.6% | ₹106 Cr ▲39.5% | ₹76 Cr |
| EPS (₹) | 3.67 ▲891.9% | 0.37 ▼77.8% | 1.67 ▼22.3% | 2.15 ▼52.7% | 4.55 ▲39.6% | 3.26 ▲23.5% | 2.64 ▲40.4% | 1.88 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.7K Cr ▲2.7% | ₹3.6K Cr ▲4.4% | ₹3.5K Cr ▲9.3% | ₹3.2K Cr ▲22.6% | ₹2.6K Cr ▲19.2% | ₹2.2K Cr ▲8.5% | ₹2.0K Cr ▲10.2% | ₹1.8K Cr ▲28.3% | ₹1.4K Cr |
| Expenses | ₹2.8K Cr ▲8.4% | ₹2.6K Cr ▲5.1% | ₹2.5K Cr ▲9.8% | ₹2.3K Cr ▲21.0% | ₹1.9K Cr ▲23.5% | ₹1.5K Cr ▲8.1% | ₹1.4K Cr ▲8.1% | ₹1.3K Cr ▲35.8% | ₹949 Cr |
| Op. Profit | ₹921 Cr ▼11.9% | ₹1.0K Cr ▲2.8% | ₹1.0K Cr ▲8.0% | ₹942 Cr ▲26.8% | ₹743 Cr ▲9.6% | ₹678 Cr ▲9.7% | ₹618 Cr ▲15.1% | ₹537 Cr ▲13.3% | ₹474 Cr |
| OPM | 25.0% ▼13.8% | 29.0% ▲0.0% | 29.0% ▼3.3% | 30.0% ▲3.4% | 29.0% ▼6.5% | 31.0% ▲0.0% | 31.0% ▲6.9% | 29.0% ▼12.1% | 33.0% |
| Other Income | ₹-9 Cr ▼108.9% | ₹101 Cr ▲31.2% | ₹77 Cr ▲22.2% | ₹63 Cr ▼16.0% | ₹75 Cr ▼20.2% | ₹94 Cr ▼38.6% | ₹153 Cr ▲104.0% | ₹75 Cr ▲41.5% | ₹53 Cr |
| Interest | ₹49 Cr ▼7.5% | ₹53 Cr ▲12.8% | ₹47 Cr ▲4.4% | ₹45 Cr ▲87.5% | ₹24 Cr ▼14.3% | ₹28 Cr ▼20.0% | ₹35 Cr ▲9.4% | ₹32 Cr ▲39.1% | ₹23 Cr |
| Depreciation | ₹453 Cr ▲4.6% | ₹433 Cr ▲1.6% | ₹426 Cr ▲16.4% | ₹366 Cr ▲18.1% | ₹310 Cr ▲13.1% | ₹274 Cr ▲25.1% | ₹219 Cr ▲33.5% | ₹164 Cr ▲25.2% | ₹131 Cr |
| PBT | ₹411 Cr ▼37.7% | ₹660 Cr ▲6.3% | ₹621 Cr ▲4.5% | ₹594 Cr ▲22.7% | ₹484 Cr ▲3.2% | ₹469 Cr ▼9.3% | ₹517 Cr ▲24.6% | ₹415 Cr ▲11.6% | ₹372 Cr |
| Tax % | 23.0% ▼8.0% | 25.0% ▲38.9% | 18.0% ▼18.2% | 22.0% ▲22.2% | 18.0% ▲28.6% | 14.0% ▼30.0% | 20.0% ▲0.0% | 20.0% ▲11.1% | 18.0% |
| Net Profit | ₹317 Cr ▼36.1% | ₹496 Cr ▼2.7% | ₹510 Cr ▲9.9% | ₹464 Cr ▲17.2% | ₹396 Cr ▼2.2% | ₹405 Cr ▼1.7% | ₹412 Cr ▲24.1% | ₹332 Cr ▲8.9% | ₹305 Cr |
| EPS (₹) | 7.86 ▼36.3% | 12.33 ▼2.8% | 12.69 ▲9.7% | 11.57 ▲17.1% | 9.88 ▼2.4% | 10.12 ▼1.7% | 10.3 ▲24.2% | 8.29 ▲8.5% | 7.64 |
| Div Payout | 16.0% ▲60.0% | 10.0% ▲0.0% | 10.0% ▼9.1% | 11.0% ▲10.0% | 10.0% | 0.0% | 0.0% ▼100.0% | 3.0% ▼57.1% | 7.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||
| Equity Capital | ₹403 Cr ▲0.2% | ₹402 Cr ▲0.0% | ₹402 Cr ▲0.2% | ₹401 Cr ▲0.0% | ₹401 Cr ▲0.3% | ₹400 Cr ▲0.0% | ₹400 Cr ▲100.0% | ₹200 Cr ▲0.0% | ₹200 Cr |
| Reserves | ₹4.4K Cr ▲2.6% | ₹4.3K Cr ▲12.1% | ₹3.9K Cr ▲19.9% | ₹3.2K Cr ▲11.0% | ₹2.9K Cr ▲19.7% | ₹2.4K Cr ▲36.3% | ₹1.8K Cr ▲0.5% | ₹1.8K Cr ▲16.3% | ₹1.5K Cr |
| Borrowings | ₹458 Cr ▼20.8% | ₹578 Cr ▲4.1% | ₹555 Cr ▼31.9% | ₹815 Cr ▼20.3% | ₹1.0K Cr ▲14.4% | ₹893 Cr ▲15.5% | ₹773 Cr ▼4.9% | ₹813 Cr ▲3.3% | ₹787 Cr |
| Other Liabilities | ₹1.8K Cr ▲17.8% | ₹1.5K Cr ▲11.4% | ₹1.3K Cr ▼4.2% | ₹1.4K Cr ▲12.3% | ₹1.2K Cr ▲6.5% | ₹1.2K Cr ▼3.7% | ₹1.2K Cr ▲31.7% | ₹922 Cr ▲35.4% | ₹681 Cr |
| Total Liabilities | ₹7.1K Cr ▲3.8% | ₹6.8K Cr ▲10.5% | ₹6.2K Cr ▲5.5% | ₹5.8K Cr ▲4.8% | ₹5.6K Cr ▲13.9% | ₹4.9K Cr ▲17.3% | ₹4.2K Cr ▲12.4% | ₹3.7K Cr ▲16.1% | ₹3.2K Cr |
| Assets | |||||||||
| Fixed Assets | ₹3.0K Cr ▲7.1% | ₹2.8K Cr ▼1.7% | ₹2.9K Cr ▲6.9% | ₹2.7K Cr ▲11.5% | ₹2.4K Cr ▲8.7% | ₹2.2K Cr ▲9.0% | ₹2.0K Cr ▲46.7% | ₹1.4K Cr ▲33.7% | ₹1.0K Cr |
| CWIP | ₹1.0K Cr ▼17.4% | ₹1.3K Cr ▲51.1% | ₹838 Cr ▲373.4% | ₹177 Cr ▼48.8% | ₹346 Cr ▲46.0% | ₹237 Cr ▲1.3% | ₹234 Cr ▼14.6% | ₹274 Cr ▲76.8% | ₹155 Cr |
| Investments | ₹741 Cr ▲14.5% | ₹647 Cr ▲18.1% | ₹548 Cr ▼40.3% | ₹918 Cr ▼11.2% | ₹1.0K Cr ▲47.3% | ₹702 Cr ▼9.5% | ₹776 Cr ▲8.4% | ₹716 Cr ▲353.2% | ₹158 Cr |
| Other Assets | ₹2.3K Cr ▲9.0% | ₹2.1K Cr ▲8.6% | ₹1.9K Cr ▼7.4% | ₹2.1K Cr ▲15.6% | ₹1.8K Cr ▲2.7% | ₹1.7K Cr ▲53.8% | ₹1.1K Cr ▼15.3% | ₹1.3K Cr ▼27.6% | ₹1.8K Cr |
| Total Assets | ₹7.1K Cr ▲3.8% | ₹6.8K Cr ▲10.5% | ₹6.2K Cr ▲5.5% | ₹5.8K Cr ▲4.8% | ₹5.6K Cr ▲13.9% | ₹4.9K Cr ▲17.3% | ₹4.2K Cr ▲12.4% | ₹3.7K Cr ▲16.1% | ₹3.2K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹915 Cr ▼21.7% | ₹1.2K Cr ▲12.1% | ₹1.0K Cr ▲26.5% | ₹824 Cr ▲41.8% | ₹581 Cr ▼17.1% | ₹701 Cr ▲3.5% | ₹677 Cr ▲7.5% | ₹630 Cr ▲41.3% | ₹446 Cr |
| Investing CF | ₹-839 Cr ▼12.8% | ₹-744 Cr ▼50.6% | ₹-494 Cr ▲24.3% | ₹-653 Cr ▼6.9% | ₹-611 Cr ▲2.9% | ₹-629 Cr ▼48.3% | ₹-424 Cr ▲34.4% | ₹-646 Cr ▼85.1% | ₹-349 Cr |
| Financing CF | ₹-215 Cr ▼51.4% | ₹-142 Cr ▲74.2% | ₹-551 Cr ▼61.1% | ₹-342 Cr ▼1003.2% | ₹-31 Cr ▼153.4% | ₹58 Cr ▲125.7% | ₹-226 Cr ▼213.9% | ₹-72 Cr ▲8.9% | ₹-79 Cr |
| Net Cash Flow | ₹-138 Cr ▼149.1% | ₹281 Cr ▲7125.0% | ₹-4 Cr ▲97.7% | ₹-172 Cr ▼177.4% | ₹-62 Cr ▼147.7% | ₹130 Cr ▲364.3% | ₹28 Cr ▲131.8% | ₹-88 Cr ▼588.9% | ₹18 Cr |
| Free Cash Flow | ₹547 Cr ▲37.4% | ₹398 Cr ▼28.0% | ₹553 Cr ▲81.3% | ₹305 Cr ▲190.5% | ₹105 Cr ▼58.8% | ₹255 Cr ▲650.0% | ₹34 Cr ▼27.7% | ₹47 Cr ▼42.7% | ₹82 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50d ▼5.7% | 53d ▲15.2% | 46d ▼24.6% | 61d ▼14.1% | 71d ▼10.1% | 79d ▲9.7% | 72d ▲5.9% | 68d ▲0.0% | 68d |
| Inventory Days | 56d ▼6.7% | 60d ▼36.2% | 94d ▼33.3% | 141d ▲62.1% | 87d ▲112.2% | 41d ▲127.8% | 18d ▼40.0% | 30d ▼63.4% | 82d |
| Days Payable | 138d ▲1.5% | 136d ▲36.0% | 100d ▼8.3% | 109d ▼3.5% | 113d ▼32.3% | 167d ▲7.1% | 156d ▲1.3% | 154d ▼21.0% | 195d |
| Cash Conv. Cycle | -32d ▼39.1% | -23d ▼157.5% | 40d ▼56.5% | 92d ▲104.4% | 45d ▲195.7% | -47d ▲28.8% | -66d ▼17.9% | -56d ▼27.3% | -44d |
| Working Capital Days | -68d ▼33.3% | -51d ▼88.9% | -27d ▼92.9% | -14d ▲67.4% | -43d ▲34.8% | -66d ▲61.6% | -172d ▼67.0% | -103d ▼114.6% | -48d |
| ROCE | 10.0% ▼23.1% | 13.0% ▼13.3% | 15.0% ▲0.0% | 15.0% ▲15.4% | 13.0% ▼7.1% | 14.0% ▼17.6% | 17.0% ▲0.0% | 17.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Syngene International Limited share price today?▾
Syngene International Limited (SYNGENE) is currently trading at ₹413.25 on NSE, down 1.04% as of the last market session. Prices update daily after market close on MarketNetra.
Is Syngene International Limited available in F&O (Futures & Options)?▾
Yes, Syngene International Limited (SYNGENE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Syngene International Limited 52-week high and low?▾
Syngene International Limited's 52-week high is ₹729 and the 52-week low is ₹380. The current price of ₹413.25 is 43.3% below the 52W high.
What is Syngene International Limited P/E ratio?▾
Syngene International Limited's current P/E ratio is 45.3. This indicates the market is paying ₹45.3 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Syngene International Limited options?▾
Syngene International Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SYNGENE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.